Offer - Urjas Oil for just ₹ 1 X
Nebistar 2.5 Tablet (15) is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of High BP.
The right dosage of Nebistar 2.5 Tablet (15) depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Nebistar 2.5 Tablet (15) have been listed ahead. These side effects of Nebistar 2.5 Tablet (15) are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Nebistar 2.5 Tablet (15)'s effect is Severe during pregnancy and Severe for lactating mothers. In addition, Nebistar 2.5 Tablet (15)'s effects on the liver, heart and kidney are discussed below in the Nebistar 2.5 Tablet (15) related warnings section.
Nebistar 2.5 Tablet (15) is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Some other conditions that can be affected by Nebistar 2.5 Tablet (15) are listed in the contraindications section below.
Additionally, Nebistar 2.5 Tablet (15) may also adversely react with other medicines. See below for a complete list.
You should also be aware that Nebistar 2.5 Tablet (15) is not safe while driving, and is not addiction.
Nebistar 2.5 Tablet (15) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nebistar 2.5 Tablet (15) safe for pregnant women?
Nebistar shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebistar 2.5 Tablet (15) safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nebistar. It should only be taken after medical advice.
What is the effect of Nebistar 2.5 Tablet (15) on the Kidneys?
Nebistar rarely affects the kidneys.
What is the effect of Nebistar 2.5 Tablet (15) on the Liver?
Very few cases of side effects of Nebistar on the liver have been reported.
What is the effect of Nebistar 2.5 Tablet (15) on the Heart?
Nebistar may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Nebistar 2.5 Tablet (15) unless your doctor advises you to do so -
Is this Nebistar 2.5 Tablet (15) habit forming or addictive?
Nebistar 2.5 Tablet (15) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Nebistar 2.5 Tablet (15) you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Nebistar 2.5 Tablet (15) only as per medical advice.
Is it able to treat mental disorders?
No, Nebistar 2.5 Tablet (15) is not used to treat mental disorders.
Interaction between Food and Nebistar 2.5 Tablet (15)
Eating certain foods may increase the time it takes Nebistar 2.5 Tablet (15) to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nebistar 2.5 Tablet (15)
Consult your doctor before consuming alcohol while taking Nebistar 2.5 Tablet (15) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897